Pharmacotherapy options for labor induction

Expert Opinion on Pharmacotherapy

Volumn 16, Issue 11, 2015, Pages 1657-1668

  Wing, Deborah A ^a   Sheibani, Lili ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Dinoprostone; Induction agents; Labor; Misoprostol; Oxytocin; Pharmacogenomics; Prostaglandins

Indexed keywords

MIFEPRISTONE; NITRIC OXIDE; OXYTOCIN; PROSTAGLANDIN; PROSTAGLANDIN E1; PROSTAGLANDIN E2; UTEROTONIC AGENT; MISOPROSTOL; OXYTOCIC AGENT;

ALTERNATIVE MEDICINE; ARTICLE; CESAREAN SECTION; CLINICAL TRIAL (TOPIC); DRUG SAFETY; DRUG STRUCTURE; FEMALE; HUMAN; LABOR INDUCTION; META ANALYSIS (TOPIC); PHARMACOGENOMICS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SIDE EFFECT; SYSTEMATIC REVIEW (TOPIC); UTERINE CERVIX RIPENING; DRUG EFFECTS; PREGNANCY; PROCEDURES;

CERVICAL RIPENING; DINOPROSTONE; FEMALE; HUMANS; LABOR, INDUCED; MISOPROSTOL; OXYTOCICS; OXYTOCIN; PREGNANCY;

EID: 84936930790     PISSN: 14656566     EISSN: 17447666     Source Type: Journal    
DOI: 10.1517/14656566.2015.1060960     Document Type: Article

References (71)

1. Hamilton BE, Martin JA, Ventura SJ. Births: preliminary data for 2012. Natl Vital Stat Rep 2013;62(3):1-20
2. American College of Obstetricians and Gynecologists. Induction of labor. ACOG Practice Bulletin No. 107. Obstet Gynecol 2009;114:386
3. American College of Obstetricians and Gynecologists. ACOG committee opinion no. 561: Nonmedically indicated early-term deliveries. Obstet Gynecol 2013;121:911
4. Calkins LA, Irvine JH, Horsley GW. Variation in the length of labor. Am J Obstet Gynecol 1930;19:294-7
5. Bishop EH. Elective induction of labor. Obstet Gynecol 1955;5:519-27
6. Bishop EH. Pelvic scoring for elective induction. Obstet Gynecol 1964;24:266-8
7. Kelly AJ, Kavanagh J, Thomas J. Vaginal prostaglandin (PGE2 and pGF2a) for induction of labour at term. Cochrane Database of Syst Rev 2003(4):CD003101
8. Hertelendy F, Zakar T. Prostaglandin and the myometrium and cervix. Prostaglandins Leukot Essent Fatty Acids 2004;70:207-22
9. Timmons B, Akins M, Mahendroo M. Cervical remodeling during pregnancy and parturition. Trends Endocrinol Metab 2010;353-61
10. French L. Oral prostaglandin E2 for induction of labor. Cochrane Database Syst Rev 2001;2:CD003098
11. Makino S, Zaragoza DB, Mitchell BF, et al. Prostaglandin F2alpha and its receptor as activators of human decidua. Semin Reprod Med 2007;25:60-8
12. Bygdeman M. Pharmacokinetics of prostaglandins. Best Pract and Res Clin Obstet Gynecol 2003;17:707-16
13. Fittkow CT, Maul H, Olson G, et al. Light-induced fluorescence of the human cervix decreased after prostaglandin application for induction of labor at term. Eur J Obstet Gynecol Reprod Biol 2005;123:62-6
14. Rath W, Osmters R, Adelmann-Grill BC, et al. Biochemical changes in human cervical connective tissue after intracervical applications of prostaglandin E2. Prostaglandins 1993;45:375-84
15. Kelly AJ, Kavanagh J, Thomas J. Vaginal prostaglandin (PGE2 and PGF2a) for induction of labour at term. Cochrane Database Syst Revi 2003(4):CD003101
16. Liggins GC. Controlled trial of induction of labor by vaginal suppositories containing prostaglandin E2. Prostaglandins 1979;18(1):167-72
17. Rayburn WF. Prostaglandin E2 gel for cervical ripening and induction of labor: A critical analysis. Am J Obstet Gynecol 1989;160:529
18. Church S, VanMeter A, Whitfield R. Dinoprostone compared with misoprostol for cervical ripening for induction of labor at term. J Mid wifery Womens Health 2009;54:405-11
19. American College of Obstetricians and Gynecologists. New U. S. Food and Drug Administration labeling on Cytotec (misoprostol) use and pregnancy ACOG Committee Opinion No. 28. Obstet Gynecol 2003;101:1049
20. Wing DA, Rahall A, Jones MM, et al. Misoprostol: An effective agent for cervical ripening and labor induction. Am Obstet Gynecol 1995;172:1804-10
21. Hofmeyr GJ, Gulmezoglu AM, Pileggi C. Vaginal misoprostol for cervical ripening and induction of labour. Cochrane Database Syst Rev 2010(10):CD000941
22. Sanchez-Ramos L, Kaunitz AM, Delke I. Labor induction with 25 microg versus 50 microg intravaginal misoprostol: a systematic review. Obstet Gynecol 2002;99(1):145-51
23. Wing DA. Misoprostol vaginal insert compared with dinoprostone vaginal insert: a randomized controlled trial. Obstet Gynecol 2008;112(4):801-12
24. Wing DA, Brown R, Plante LA, et al. Misoprostol vaginal insert and time to vaginal delivery: a randomized controlled trial. Obstet Gynecol 2013;122(2 pt 1):201-9
25. Alfirevic Z, Weeks A. Oral misoprostol for induction of labour. Cochrane Database Syst Rev 2006;19(2):CD001338
26. Hofmeyr GJ, Alfirevic Z, Matonhodze B, et al. Titrated oral misoprostol solution for induction of labour: A multi-centre, randomised trial. Br J Obstet Gynecol 2001;108:952
27. Alfirevic Z, Aflaifel N, Weeks A. Oral misoprostol for induction of labour. Cochrane Database of Syst Rev 2014;6:CD001338
28. Shetty A, Mackie L, Danielian P, et al. Sublingual compared with oral misoprostol in term labour induction: A randomised controlled trial. Br J Obstet Gynaecol 2002;109:645
29. Carlan S, Blust D, O'Brien W. Buccal versus intravaginal misoprostol administration for cervical ripening. Am J Obstet Gynecol 2002;186:229
30. Kelly AJ, Tan B. Intravenous oxytocin alone for cervical ripening and induction of labour. Cochrane Databae Syst Rev 2001;3:CD003246
31. Laughon KS, Zhang J, Grewal J, et al. Induction of labor in a contemporary obstetric cohort. Am J Obstet Gynecol 2012;206(6):486
32. Lyndrup J, Legarth J, Dahl C, et al. Induction of labour: The effect of vaginal prostaglandin or i. v. oxytocin - a matter of time only? Eur J Obstet Gynecol Reprod Biol 1990;37:111
33. Pollnow DM, Broekhuizen FF. Randomized, double-blind trial of prostaglandin E2 intravaginal gel versus low-dose oxytocin for cervical ripening before induction of labor. Am J Obstet Gynecol 1996;174:1910
34. Satin AJ, Leveno KJ, Sherman ML, et al. High-versus low-dose oxytocin for labor stimulation. Obstet Gynecol 1992;80:111
35. Merrill DC, Zlatnik FJ. Randomized double-masked comparison of oxytocin dosage in induction and augmentation of labor. Obstet Gynecol 1999;94:455
36. Girard B, Vardon D, Creveuil C, et al. Discontinuation of oxytocin in the active phase of labor. Acta Obstet Gynecol Scand 2009;88:172
37. Vlachos DE, Pergialiotis V, Papantonious N, et al. Oxytocin discontinuation after the active phase of labor is established. J Matern Fetal Neonatal Med 2014;18:1-7
38. Hayes EJ, Weinstein L. Improving patient safety and uniformity of care by a standardized regimen for the use of oxytocin. Am J Obstet Gynecol 2008;198:622
39. Freeman RK, Nageotte M. A protocol for use of oxytocin. Am J Obstet Gynecol 2007;197:445
40. Clark S, Belfort M, Saade G, et al. Implementation of a conservative checklist-based protocol for oxytocin administration: maternal and newborn outcomes. Am J Obstet Gynecol 2007;197:480
41. Terkawi A, Jackson W, Thiet M, et al. Oxytocin and catechol-O-methyltransferase receptor genotype predict the length of the first stage of labor. Am J Obstet Gynecol 2012;207(3):184e1-8
42. Whalley PJ, Pritchard JA. Oxytocin and water intoxication. JAMA 1963;186:601
43. Feeney JG. Water intoxication and oxytocin. Br Med J (Clin Res Ed) 1982;285(6337):243
44. Davies GA, Tessier JL, Woodman MC, et al. Maternal hemodynamics after oxytocin bolus compared with infusion in the third stage of labor: A randomized controlled trial. Obstet Gynecol 2005;105:294
45. Jonsson M, Hanson U, Lidell C, Norden-Lindeberg S. ST depression at cesarean section and the relation to oxytocin dose. A randomised controlled trial. BJOG 2010;117(1):76-83
46. Gregory SG, Anthopolos R, Osgood CE, et al. Association of autism with induced or augmented childbirth in North Carolina Birth Record (1990-1998) and Education Research (1997-2007) database. JAMA pediatr 2013;167(10):959-66
47. Jacob S, Brune CW, Carter CS, et al. Association of oxytocin receptor gene (OXTR) in caucasian children and adolescents with autism. Neurosci Lett 2007;417(1):6-9
48. Smith AJ, Merrill DC. Oxytocin for induction of labor. Clin Obstet Gynecol 2006;49:594
49. Wing DA, Ortiz-Omphroy G, Paul RH. A comparison of intermittent vaginal administration of misoprostol with dinoprostone for cervical ripening and labor induction. Am J Obstet Gynecol 1997;177:612
50. Wing DA, Miller H, Parker L, et al. Misoprostol vaginal insert for successful labor induction: a randomized controlled trial. Obstet Gynecol 2011;117:533
51. Tan PC, Daud SA, Omar SZ. Concurrent dinoprostone and oxytocin for labor induction in term premature rupture of membranes: a randomized controlled trial. Obstet Gynecol 2009;113:1059
52. Hapangama D, Neilson JP. Mifepristone for induction of labour. Cochrane Database Syst Rev 2009(3):CD002865
53. Frydman R, Lelaidier C, Baton-Saint Mieux C, et al. Labor induction in women at term with mifepristone (RU 486): A double-blind, randomized placebo-controlled study. Obstet Gynecol 1992;80:972-5
54. Elliot CL, Brennand JE, Calder AA. The effect of mifepristone on cervical ripening and labor induction in primigravidae. Obstet Gynecol 1998;92:804-9
55. Ekerhovd E, Bullarbo M, Andersch B, Norström A. Vaginal administration of the nitric oxide donor isosorbide mononitrate for cervical ripening at term: a randomized controlled study. Am J Obstet Gynecol 2003;189(6):1692-7
56. Bollapragada SS, MacKenzie F, Norrie JD, et al. Randomised placebocontrolled trial of outpatient (at home) cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour-clinical trial with analyses of efficacy and acceptability. The IMOP Study. BJOG 2009;116(9):1185-95
57. Jozwiak M, Dodd JM. Methods of term labour induction for women with a previous caesarean section. Cochrane Database Syst Rev 2013;3:CD009792
58. Palatnik A, Grobman WA. Induction of labor versus expectant management for women with a prior cesarean delivery. Am J Obstet Gynecol 2015;212(3):358
59. Landon MB, Hauth JC, Leveno KJ, et al. Maternal and perinatal outcomes associated with a trial of labor after prior cesarean delivery. N Engl J Med 2004;351(25):2581-9
60. American College of Obstetricians and Gynecologists. Vaginal birth after previous cesarean delivery. ACOG Practice Bulletin No. 115. Obstet Gynecol 2010;116:450
61. Harper LM, Cahill AG, Boslaugh S, et al. Association of induction of labor and uterine rupture in women attempting vaginal birth after cesarean: a survival analysis. Am J Obstet Gynecol 2012;206:51
62. Lydon-Rochelle M, Holt VL, Easterling TR, Martin DP. Risk of uterine rupture during labor among women with prior cesarean delivery. N Engl J Med 2001;345:3
63. McDonagh MS, Osterweil P, Guise JM. The benefits and risks of inducing labour in patients with prior caesarean delivery: a systematic review. BJOG 2005;112:1007
64. Cahill AG, Stamillo DM, Odibo AO, et al. Does a maximum dose of oxytocin affect risk for uterine rupture in candidates for vaginal birth after cesarean delivery. Am J Obstet Gynecol 2012;206:51
65. Cahill AG, Waterman BM, Stamillo DM, et al. Higher maximum doses are associated with an unacceptably high risk for uterine rupture in patients attempting vaginal birth after cesarean delivery. Am J Obstet Gynecol 2008;199:32
66. American College of Obstetrics and Gynecology Committee on Practice Bulletins-Obstetrics. ACOG Practice Bulletin Number 49, December 2003: Dystocia and augmentation of labor. Obstet Gynecol 2003;102:1445
67. Centers for Disease Control and Prevention (CDC). Use of hospital discharge data to monitor uterine rupture-Massachusetts, 1990-1997. MMWR Morb Mortal Wkly Rep 2000;49:245
68. Macones GA, Peipert J, Nelson DB, et al. Maternal complications with vaginal birth after cesarean delivery: a multicenter study. Am J Obstet Gynecol 2005;193:1656
69. Schmitz T, Pourcelot AG, Moutafoff C, et al. Cervical ripening with low-dose prostaglandins in planned vaginal birth after cesarean. PLoS ONE 2013;8:e80903
70. Love TM, Enoch M, Hodgkinson C, et al. Oxytocin Gene Polymorphisms Influence Dopaminergic Function in a Sex Dependent Manner. Biol Psychiatry 2012;72(3):198-206
71. Mozurkewich E, Chilimigras J, Koepke E, et al. Indications for induction of labour: a best-evidence review. BJOG 2009;116(5):626